CTMX vs AMGN: Which Stock is Better?
Side-by-side comparison of CytomX Therapeutics Inc and Amgen Inc in 2026
CTMX
CytomX Therapeutics Inc
$5.37
AMGN
Amgen Inc
$331.00
Key Metrics Comparison
| Metric | CTMX | AMGN | Winner |
|---|---|---|---|
| Market Cap | $913.26M | $177.92B | AMGN |
| P/E Ratio | 17.97 | 25.57 | CTMX |
| EPS (TTM) | $0.30 | $12.92 | AMGN |
| Revenue Growth | -0.8% | 0.1% | AMGN |
| Gross Margin | 100.0% | 70.1% | CTMX |
Analyze CTMX
Full quant analysis
Analyze AMGN
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is CTMX or AMGN a better investment?
Comparing CTMX and AMGN: CytomX Therapeutics Inc has a market cap of $913.26M while Amgen Inc has $177.92B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between CTMX and AMGN?
CTMX (CytomX Therapeutics Inc) and AMGN (Amgen Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: CTMX or AMGN?
Based on P/E ratios, CTMX trades at a lower multiple (18.0x vs 25.6x).
Which is growing faster: CTMX or AMGN?
AMGN has higher revenue growth at 0.1% vs -0.8% for CTMX.
Which company is more profitable: CTMX or AMGN?
CytomX Therapeutics Inc (CTMX) has higher gross margins at 100.0% compared to 70.1% for AMGN.
Which is the larger company: CTMX or AMGN?
Amgen Inc (AMGN) is larger with a market cap of $177.92B compared to $913.26M for CTMX.
Should I buy CTMX or AMGN in 2026?
Both CTMX and AMGN have investment merit. CTMX trades at $5.37 while AMGN trades at $331.00. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between CTMX and AMGN stock?
Key differences: Market Cap ($913.26M vs $177.92B), P/E Ratio (18.0x vs 25.6x), Revenue Growth (-0.8% vs 0.1%), Gross Margin (100.0% vs 70.1%).